Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 million from group lead by the company’s former chief executive officer, Anne Wojcicki.The new offer is nearly $50 million more than the last bid from Regeneron Pharmaceuticals, which had been declared the winner of the first auction last month, only to have the outcome challenged in court by Wojcicki....